Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.6 - $11.2 $1.11 Million - $3.46 Million
-309,187 Reduced 57.1%
232,267 $1.01 Million
Q1 2022

May 16, 2022

SELL
$8.58 - $17.65 $1.11 Million - $2.29 Million
-129,666 Reduced 19.32%
541,454 $6.3 Million
Q4 2021

Feb 11, 2022

BUY
$10.17 - $18.96 $781,147 - $1.46 Million
76,809 Added 12.92%
671,120 $12.3 Million
Q3 2021

Nov 15, 2021

SELL
$11.67 - $18.07 $21.1 Million - $32.7 Million
-1,811,106 Reduced 75.29%
594,311 $7.04 Million
Q2 2021

Aug 16, 2021

BUY
$16.25 - $21.51 $2.79 Million - $3.7 Million
171,919 Added 7.7%
2,405,417 $41.3 Million
Q1 2021

May 17, 2021

BUY
$17.92 - $25.86 $13.1 Million - $18.9 Million
731,953 Added 48.75%
2,233,498 $40.8 Million
Q4 2020

Feb 12, 2021

BUY
$18.13 - $25.18 $1.35 Million - $1.88 Million
74,574 Added 5.23%
1,501,545 $28.3 Million
Q3 2020

Nov 16, 2020

SELL
$17.83 - $29.12 $9.22 Million - $15.1 Million
-516,970 Reduced 26.59%
1,426,971 $30.1 Million
Q2 2020

Aug 14, 2020

BUY
$27.86 - $35.93 $37.3 Million - $48.1 Million
1,338,717 Added 221.19%
1,943,941 $56.1 Million
Q1 2020

May 14, 2020

BUY
$23.65 - $40.96 $3.14 Million - $5.43 Million
132,621 Added 28.06%
605,224 $21.2 Million
Q4 2019

Feb 11, 2020

BUY
$13.55 - $26.15 $6.4 Million - $12.4 Million
472,603 New
472,603 $11.6 Million

Others Institutions Holding OYST

About Oyster Point Pharma, Inc.


  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.